A policy prescription for reducing health disparities—achieving pharmacoequity

UR Essien, SB Dusetzina, WF Gellad - Jama, 2021 - jamanetwork.com
In 2019, the US spent $3.8 trillion on health care, including an estimated $370 billion on
retail prescription drugs alone. 1 Onaverage, individualsintheUSspendmorethan $1100 per …

Financial burden of drugs prescribed for cancer-associated symptoms

A Gupta, L Nshuti, US Grewal, R Sedhom… - JCO Oncology …, 2022 - ascopubs.org
PURPOSE: The financial toxicity of anticancer drugs is well-documented, but little is known
about the costs of drugs used to manage cancer-associated symptoms. METHODS: We …

A systematic review of independent and chain pharmacies effects on medication adherence

J Nind, A Smith, S Scahill, CA Marra - Pharmacy, 2022 - mdpi.com
As the last step in the care pathway, pharmacies can significantly impact a patient's
medication adherence and the success of treatment. The potential impact of patient's …

Retail pharmacies and drug diversion during the opioid epidemic

A Janssen, X Zhang - American economic review, 2023 - aeaweb.org
This study investigates the role of retail pharmacy ownership in the opioid epidemic. Using
data of prescription opioid orders, we show that compared with chain pharmacies …

Inequities in filled overactive bladder medication prescriptions in the US

D Luchristt, CE Bretschneider, K Kenton… - JAMA network …, 2023 - jamanetwork.com
Importance Anticholinergic medications to treat overactive bladder (OAB) have been
associated with increased risk of cognitive decline, whereas β3-adrenoceptor agonists …

Availability and cost of expensive and common generic prescription drugs: a cross-sectional analysis of direct-to-consumer pharmacies

HS Lalani, FA Tessema, AS Kesselheim… - Journal of General …, 2024 - Springer
Background Direct-to-consumer (DTC) pharmacies sell generic prescription drugs, often at
lower prices than traditional retail pharmacies; however, not all drugs are available, and …

Out-of-pocket costs for prostate cancer medications substantially vary by Medicare Part D plan: an online tool presents an opportunity to mitigate financial toxicity

B Pockros, C Shabet, K Stensland, L Herrel - Urology practice, 2023 - auajournals.org
Introduction: Patients with advanced prostate cancer are frequently prescribed enzalutamide
or abiraterone, often requiring high out-of-pocket costs. Many of these patients are insured …

Characteristics of copayment offsets for prescription drugs in the United States

AP Sen, SY Kang, E Rashidi, D Ganguli… - JAMA internal …, 2021 - jamanetwork.com
Importance Despite ongoing debate regarding the high prices that patients pay for
prescription drugs, to our knowledge, little is known regarding the use of coupons, vouchers …

[HTML][HTML] Variation of prescription drug prices in community pharmacies: A national cross-sectional study

J Larkin, F Moriarty, S McGuinness, K Finucane… - Research in Social and …, 2022 - Elsevier
Background; There is evidence of significant variation of prescription drug prices in
community pharmacies in several countries. Prescription drugs are a major source of …

Association Between Prescription Drug Discount Cards and Out-of-Pocket Costs for HFrEF Regimens

JS Wheeler, RE Heidel, A Dong… - … Quality and Outcomes, 2023 - Am Heart Assoc
BACKGROUND: The burden from medication costs for treating heart failure can be
financially toxic for uninsured/underinsured patients and their families. Prescription discount …